Corvus Pharmaceuticals, Inc. (FRA:C17)
7.50
+0.32 (4.46%)
At close: Dec 5, 2025
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of €565.57 million as of December 5, 2025. Its market cap has increased by 10.95% in one year.
Market Cap
565.57M
Enterprise Value
509.97M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.50
Market Cap Chart
Since March 24, 2016, Corvus Pharmaceuticals's market cap has increased from 260.30M to 565.57M, an increase of 117.28%. That is a compound annual growth rate of 8.32%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 97.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.46B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |